|
Market Closed -
Bombay S.E.
11:02:22 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 127.95 INR | -4.23% |
|
+1.91% | +77.98% |
| 08-07 | ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026 | |
| 08-06 | ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 6.85B 72.48M 62.36M 58.52M 53.54M 99.93M 101M 692M 270M 3.5B 272M 266M 11.28B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.71B 81.61M 70.22M 65.89M 60.29M 113M 113M 779M 304M 3.94B 306M 300M 12.7B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript : ZIM Laboratories Limited
| 1 day | -4.23% | ||
| 1 week | +1.91% | ||
| Current month | +3.48% | ||
| 1 month | +12.43% | ||
| 3 months | +25.75% | ||
| 6 months | +86.57% | ||
| Current year | +77.98% |
| 1 week | 112 |  | 136.8 |
| 1 month | 105.8 | | 136.8 |
| Current year | 59.72 | | 136.8 |
| 1 year | 59.72 | | 136.8 |
| 3 years | 59.72 | | 136.8 |
| 5 years | 36.37 | | 151.75 |
| 10 years | 14 | | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 31/12/2001 |
| Director of Finance/CFO | - | 31/03/2019 | |
| Director of Finance/CFO | - | 31/12/1990 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 31/12/1989 |
| Director/Board Member | - | 31/12/1990 | |
Prakash Sapkal
BRD | Director/Board Member | - | 31/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.23% | +1.91% | +68.36% | -1.35% | 75.73M | |
| -0.81% | +0.87% | +22.41% | +72.77% | 49.06B | |
| +0.41% | +0.12% | +52.20% | +121.38% | 40.37B | |
| -0.97% | -0.61% | +14.75% | +86.17% | 12.19B | |
| -1.28% | -0.57% | -11.12% | +11.99% | 12.08B | |
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | |
| +0.08% | -3.68% | +23.29% | +42.89% | 7.36B | |
| -0.04% | +0.85% | +28.15% | +224.81% | 7.35B | |
| +0.81% | -0.04% | +45.87% | -10.06% | 7.32B | |
| +0.03% | -1.75% | -40.80% | +14.39% | 5.19B | |
| Average | -0.54% | +0.39% | +23.21% | +71.61% | 15.01B | |
| Weighted average by Cap. | -0.26% | +0.37% | +26.81% | +86.82% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 40.11M 34.51M 32.38M 29.63M 55.3M 55.74M 383M 149M 1.94B 151M 147M 6.24B | 3.74B 39.61M 34.08M 31.98M 29.26M 54.61M 55.04M 378M 147M 1.91B 149M 145M 6.16B |
| Net income | 122M 1.29M 1.11M 1.04M 951K 1.77M 1.79M 12.29M 4.79M 62.17M 4.83M 4.73M 200M | 58.38M 618K 531K 499K 456K 852K 858K 5.9M 2.3M 29.83M 2.32M 2.27M 96.09M |
| Net Debt | 1.16B 12.25M 10.54M 9.89M 9.05M 16.88M 17.02M 117M 45.55M 592M 45.99M 44.98M 1.91B | 863M 9.13M 7.86M 7.37M 6.74M 12.59M 12.69M 87.21M 33.96M 441M 34.29M 33.54M 1.42B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | ₹127.95 | -4.23% | 14,352 |
| 02/09/26 | ₹133.60 | +12.36% | 51,670 |
| 01/09/26 | ₹118.90 | -3.84% | 1,968 |
| 31/08/26 | ₹123.65 | -1.08% | 7,885 |
| 28/08/26 | ₹125.00 | +0.16% | 2,439 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
